Skip to main content
. 2024 Oct 24;16(21):3607. doi: 10.3390/nu16213607

Table 2.

Bivariable analysis between variables at baseline and the progression of plaque at the follow-up.

Variables Progression
OR (95% CI) p
Age (years) 1.03 (1.01–1.04) <0.001
Sex (women) 0.80 (0.69–0.93) 0.003
Caucasian 0.50 (0.13–2.04) 0.340
Hypertension 1.23 (1.05–1.43) 0.009
Dyslipidemia 1.29 (1.11–1.43) 0.001
Smoking 1.30 (1.06–1.43) 0.007
Physical activity (METS) 1.00 (1.00–1.00) 0.480
BMI (kg/m2) 0.99 (0.97–1.00) 0.173
Waist (cm) 1.00 (0.99–1.00) 0.535
sBP (mmHg) 1.01 (1.01–1.02) <0.001
dBP (mmHg) 1.02 (1.01–1.02) <0.001
HbA1c (%) 1.67 (1.36–2.05) <0.001
TC (mmol/L) 1.24 (1.13–1.37) <0.001
HDL (mmol/L) 1.03 (0.83–1.27) 0.804
LDL (mmol/L) 1.25 (1.11–1.42) <0.001
TG (mmol/L) 1.15 (1.04–1.27) 0.005
eGFR (mL/min/1.73 m2) 1.00 (1.00–1.00) 0.098
REGICOR score 1.18 (1.13–1.22) <0.001
MEDAS score 0.98 (0.94, 1.03) 0.430
Lifestyle
 Mild lifestyle 0.86 (0.71–1.05) 0.137
 Moderate lifestyle 0.94 (0.77–1.14) 0.538
 Healthy lifestyle 0.93 (0.74–1.17) 0.552

Unhealthy lifestyle was the reference group. BMI, body mass index; dBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; HbA1c, glycated hemoglobin; HDL, high density lipoprotein; IPAQ, international physical activity questionnaire; LDL, low density lipoprotein; METS, Metabolic Equivalent Task; p, p-value; sBP, systolic blood pressure; TC, total cholesterol; TG, triglycerides; OR, odds ratio; CI, confidence interval.